Opinion
Video
Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions
Key Takeaways
- Enhancing physician awareness and understanding of SGLT2 inhibitors and GLP1-receptor agonists can increase prescription rates.
- Streamlining insurance approval processes and advocating for policy changes are crucial for improving medication coverage.
EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity
EP: 2.Strategies for Prevention and Screening of CRM Conditions
EP: 3.The Link Between Obesity and CRM Conditions
EP: 4.Challenges in Managing Co-Morbid CRM Conditions
EP: 5.Contemporary Guidelines for CRM Conditions
EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions
Now Viewing
EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions
Video content above is prompted by the following:
- Despite being approved for first-line treatment, medications such as SGLT2 inhibitors and GLP1-receptor agonists are not frequently prescribed to qualified patients. What has been effective in your practice to get these first line medications covered in the patient population who needs it the most?
This activity is supported by an educational grant from Boehringer Ingelheim.
Related Videos
Related Content
